Study to Assess the Effect of BMS-790052 on the Pharmacokinetics of Ortho Tri-Cyclen® in Healthy Female Subjects

Completed · Phase 1

Conditions studied: Chronic Hepatitis C

In brief

The purpose of this study is to assess the effect of BMS-790052 on the pharmacokinetics of Ortho Tri-Cyclen® in healthy female subjects.

Key facts

Study ID

NCT00983957

Run by

Bristol-Myers Squibb

People needed

47

Starts

2009-10-01

Expected to finish

2010-02-01

Last updated by the study team

2015-10-16

Who can join

Age: 18 and older, up to 45. Sex: female. Healthy volunteers: accepted.

Where it is running

• MDS Pharma Services (US), Inc — Tempe, Arizona, United States
• Covance Clinical Research Unit, Inc. — Austin, Texas, United States
• Local Institution — Saint-Laurent, Quebec, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.